CatenaBio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Investors
  • 28

CatenaBio General Information

Description

Developer of antibody-drug conjugates designed to treat multiple diseases. The company offers precise multi-payload conjugation, stable protein attachment, and flexible payload integration, enabling biopharmaceutical researchers to develop targeted therapies with improved therapeutic performance.

Contact Information

Website
www.catenabio.com
Formerly Known As
Catena Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2625 Durant Avenue
  • Berkeley, CA 94720
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • 2625 Durant Avenue
  • Berkeley, CA 94720
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CatenaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A) 10-Apr-2025 Cancelled Pre-Clinical Trials
13. Seed Round 20-Dec-2024 Completed Pre-Clinical Trials
12. Accelerator/Incubator 15-Jul-2022 Completed Pre-Clinical Trials
11. Seed Round 01-Apr-2022 Completed Pre-Clinical Trials
10. Grant 17-Sep-2021 Completed Pre-Clinical Trials
9. Seed Round 01-Sep-2021 Completed Pre-Clinical Trials
8. Accelerator/Incubator 21-Jul-2021 Completed Pre-Clinical Trials
7. Accelerator/Incubator 01-Jul-2021 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Apr-2021 Completed Startup
5. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view CatenaBio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CatenaBio Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

CatenaBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198710-A1 Trop2 antibodies and conjugates and linker payloads Pending 19-Mar-2025
AU-2024397484-A1 Tyrosinase-based conjugate compositions and methods of use Pending 14-Dec-2023
EP-4824077-A1 Tyrosinase-based conjugate compositions and methods of use Pending 14-Dec-2023
WO-2025129098-A1 Tyrosinase-based conjugate compositions and methods of use Inactive 14-Dec-2023
AU-2024340257-A1 Polypeptide conjugation compositions and methods of use Pending 11-Sep-2023 A61K47/68031
To view CatenaBio’s complete patent history, request access »

CatenaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CatenaBio Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
Freeflow Ventures Venture Capital Minority
LongeVC Venture Capital Minority
QB3 Accelerator/Incubator Minority
StoryHouse Ventures Venture Capital Minority
You’re viewing 5 of 28 investors. Get the full list »

Ready to get started?

Request a free trial

CatenaBio FAQs

  • When was CatenaBio founded?

    CatenaBio was founded in 2020.

  • Where is CatenaBio headquartered?

    CatenaBio is headquartered in Berkeley, CA.

  • What is the size of CatenaBio?

    CatenaBio has 10 total employees.

  • What industry is CatenaBio in?

    CatenaBio’s primary industry is Drug Discovery.

  • Is CatenaBio a private or public company?

    CatenaBio is a Private company.

  • What is CatenaBio’s current revenue?

    The current revenue for CatenaBio is .

  • How much funding has CatenaBio raised over time?

    CatenaBio has raised $9.1M.

  • Who are CatenaBio’s investors?

    ACS BrightEdge, Freeflow Ventures, LongeVC, QB3, and StoryHouse Ventures are 5 of 28 investors who have invested in CatenaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process